Abridge

Series ABiotechnologyprivate

AI medical scribe platform converting patient-physician conversations into structured clinical notes.

Valuation
$150M
Total Funding
$30M
Stage
Series A
Sector
Biotechnology
Headquarters
Pittsburgh, PA
CEO
Shivdev Rao
IPO Status
private

Funding History

Round Amount Date
Series A $30M Dec 2022
Seed $3M Sep 2018

Track Abridge IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO โ€” the pre-IPO intelligence platform.

Loading company data...